• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

David Littlejohn - Articles and news items

PAT Supplement 2013

Process Analytical Technology (PAT): In-depth focus 2013

Issue 6 2013, PAT & QbD, Supplements / 16 December 2013 / Morten Allesø, Anette Seo Torstenson, Mette Bryder and Per Holm, Chemical & Pharmaceutical Research (H. Lundbeck A/S), Anneleen Burggraeve, Tom Van den Kerkhof, Jeroen Geens, Lieve Bijnens and Mario Hellings (Johnson & Johnson)

Presenting a rational approach to QbD-based pharmaceutical development: A roller compaction case study
PAT for pharmaceutical spray drying
PAT Roundtable
Show Preview: IFPAC® 2014

PAT in the pharmaceutical industry

Issue 4 2007 / 21 July 2007 / Don Arnone, Teraview / Gawayne Mahboubian-Jones, Optimal Automation / Vinod Mehta, Carl Zeiss / Christian Woelbeling, Werum Software & Systems AG / Denise Root, Foss / Ingrid Maes, Siemens / Chris Hobbs, ABB

European Pharmaceutical Review brings you a comprehensive guide to the current developments and possible future innovations within Process Analytical Technologies.

Cost, knowledge and convenience: facing the facts

Issue 1 2006, Past issues / 2 February 2006 / Professor David Littlejohn, Head of the Department of Pure and Applied Chemistry at the University of Strathclyde, Director of CPACT at the University of Strathclyde

There can be no doubt that the FDA’s initiative on Process Analytical Technologies (PAT) has had an enormous impact on the pharmaceutical industries. However, the emergence of ’born again‘ PAT devotees in pharma companies has caused mild amusement in other industries where on-line analysis has been an integral part of process monitoring and control for a long time.

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +